Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks

Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

Freddie Bray, Ahmedin Jemal, Nathan Grey et al. · The Lancet Oncology · 2012 · 2.2K citations

Medicine, Human Development, Oncology +16

Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes

Harald Breivik, Nathan I. Cherny, Brent R. Collett et al. · Annals of Oncology · 2009 · 794 citations

Medicine, Oncology, Oncology Nursing +16

Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist

Klaus Linz, Thomas Christoph, Thomas Tzschentke et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 166 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Effect of nociceptin/orphanin FQ on the rewarding properties of morphine

Roberto Ciccocioppo, Stefania Angeletti, Pietro Paolo Sanna et al. · European Journal of Pharmacology · 2000 · 137 citations

Medicine, Neuroscience, Pharmacology +14

Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings

Sebastiano Mercadante, Federica Aielli, Claudio Adile et al. · Journal of Pain and Symptom Management · 2015 · 107 citations · Full text

Medicine, Oncology, Oncology Nursing +16